King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Mahasen Saleh
Dr. Mahasen Saleh is a senior Consultant in Paediatric Hematology / Oncology based in Riyadh, Saudi Arabia, with American Board certifications in both Pediatrics and Pediatric Hematology-Oncology and advanced research training in the United States. A recognised pediatric hematology specialist Riyadh, Saudi Arabia, she focused on non-malignant paediatric blood disorders, hemophilia, hemoglobinopathies, and bone marrow failure for over three decades.
- 40+ years of experience in paediatrics and paediatric hematology / oncology.
- MBBS (1987); American Board in Pediatrics & Pediatric Hematology-Oncology.
- Research fellowship in paediatric hematology in the United States, 1988–1989.
- Spearheaded the section of Non-Malignant Blood Disorders for 8 years.
- Principal investigator on three major PI projects and numerous international collaborations.
Qualifications & Credentials
Medical Degrees
- MBBS — King Saud University, Riyadh, Saudi Arabia, 1987
- Registrar — Pediatrics / Paediatric Hematology-Oncology, Ain Shams University, Egypt, 1979–1982
Fellowships & Special Training
- Hematology Training — Yorkhill, Glasgow, United Kingdom, 1987
- Research Fellowship — Michigan Children Hospital Hematology, USA, 1988–1989
- Assistant & Associate Professor of Paediatrics / Paediatric Hematology-Oncology, 1986–1996
Certifications & Accreditations
- American Board of Pediatrics (ABP)
- American Board of Pediatric Hematology-Oncology
- Saudi Commission for Health Specialties (SCFHS) Registration
- Member — American Society of Hematology (ASH)
- Member — Société Internationale d'Oncologie Pédiatrique (SIOP)
Areas of Expertise
Major Conditions Treated
- Hemophilia A & B
- von Willebrand Disease
- Rare Inherited Bleeding Disorders
- Sickle Cell Disease
- Thalassemia
- Aplastic Anemia & Bone Marrow Failure Syndromes
- Immune Thrombocytopenia (ITP)
- Paediatric Thrombosis
- Glanzmann Thrombasthenia
- Factor VIII / IX Deficiency
- Paediatric Hematological Emergencies (including COVID-19 impact)
Sub-specialties
- Hemophilia & Rare Bleeding Disorders: Directs comprehensive care for paediatric hemophilia and rare bleeding disorders using standard and extended half-life factor products — a recognised pediatric hematology specialist Riyadh, Saudi Arabia for best hemophilia treatment.
- Hemoglobinopathies & Bone Marrow Failure: Long-term management of children with sickle cell disease, thalassemia, aplastic anemia, and rare bone marrow failure syndromes, including counselling for HSCT referral.
- Immune Tolerance & Factor Inhibitors: Expertise in immune tolerance induction and inhibitor management in severe hemophilia A, a focus of the Saudi hemophilia programme.
Advanced Procedures & Treatments
- Prophylactic & On-Demand Factor VIII / IX Replacement
- Extended Half-Life Factor Products
- Emicizumab Prophylaxis for Hemophilia A
- Immune Tolerance Induction for FVIII Inhibitors
- Chronic Transfusion Programmes for SCD & Thalassemia
- Iron Chelation Therapy
- Hydroxyurea Therapy for Sickle Cell Disease
- HSCT Referral & Post-HSCT Haematological Follow-Up
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia — Consultant, Paediatric Hematology / Oncology, Non-Malignant Blood Disorders Section (Present)
Past Affiliations
- Ain Shams University, Cairo, Egypt — Registrar, Pediatrics / Paediatric Hematology-Oncology, 1979–1982
- Yorkhill Hospital, Glasgow, United Kingdom — Hematology Training, 1987
- Michigan Children Hospital, USA — Research Fellow in Hematology, 1988–1989
- Assistant & Associate Professor of Paediatrics / Paediatric Hematology-Oncology, 1986–1996
Academic & Research Roles
- Spearheaded the Section of Non-Malignant Blood Disorders for 8 years
- Associate Professor equivalent — paediatric hematology teaching
- Invited speaker — International Conference on Hemophilia and Rare Bleeding Disorder
Key Achievements
- Principal investigator on 3 major PI (performance improvement) projects
- Lead Saudi investigator — immune tolerance experience for hemophilia A
- 40+ years of clinical and academic experience in paediatric hematology
- Extensive research record on hemophilia, coagulation, and paediatric COVID-19 hematological changes
Awards & Recognitions
National & International Awards
- Principal Investigator — Three performance improvement (PI) awards in hemophilia / non-malignant hematology
Professional Memberships
- American Society of Hematology (ASH)
- Société Internationale d'Oncologie Pédiatrique (SIOP)
- World Federation of Hemophilia (WFH) — Saudi delegate
- Saudi Pediatric Hematology Oncology Society
Research & Publications
Published Papers (Selected)
- Saleh M, Alkofide A, Alshammari A, Siddiqui K, Owaidah T. Changes in Hematological, Clinical and Laboratory Parameters for Children with COVID-19: Single-Center Experience. J Blood Med. 2021;12:819–826.
- Owaidah T, …, Alzahrani HA, Saleh M, et al. Assessing the Performance of Extended Half-Life Coagulation Factor VIII, Fc Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients. Adv Hematol. 2020.
- Owaidah T, Bakr S, Al-Numair N, AbaAlkhail H, Alzahrani H, Saleh M, et al. Genotype Hemophilia Screening Program Identified Novel Variants Causing a Pathogenic Variant of the Factor 8 Gene. Clin Appl Thromb Hemost. 2023.
Ongoing Research & Clinical Interests
- Immune tolerance induction in severe hemophilia A with inhibitors
- Genotype-phenotype correlation in Saudi hemophilia patients
- Paediatric blood disorders: sickle cell disease, thalassemia, bone marrow failure
- Clinical outcomes of COVID-19 in paediatric haematology patients
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Paediatric Hematology / Oncology Consultation | ₹1,500 – ₹3,500 | $18 – $42 |
| Paediatric Chemotherapy (per cycle) | ₹30,000 – ₹2,00,000 | $360 – $2,400 |
| Paediatric Bone Marrow Transplant (Allogeneic) | ₹20,00,000 – ₹35,00,000 | $24,000 – $42,000 |
| Paediatric CAR T-cell Therapy | ₹1,50,00,000 – ₹3,50,00,000 | $1,80,000 – $4,20,000 |
| HLA Typing & Donor Evaluation | ₹20,000 – ₹60,000 | $240 – $720 |
Frequently Asked Questions
1. What advanced technologies does Dr. Mahasen Saleh use in Paediatric Hematology — Non-Malignant Blood Disorders treatment?
Dr. Mahasen Saleh uses modern paediatric haematology tools including standard and extended half-life factor products for hemophilia, emicizumab prophylaxis, immune tolerance induction for FVIII inhibitors, hydroxyurea and chronic transfusion programmes for sickle cell disease, iron chelation for thalassemia, and structured HSCT referral pathways. Cancer Rounds can coordinate virtual pre-travel review of paediatric records for international families.
2. What conditions does Dr. Mahasen Saleh specialize in treating?
Dr. Mahasen Saleh specialises in paediatric hemophilia and rare bleeding disorders, sickle cell disease, thalassemia, aplastic anemia, bone marrow failure syndromes, paediatric immune thrombocytopenia, factor VIII/IX deficiencies, and Glanzmann thrombasthenia — making her a trusted pediatric hematology specialist Riyadh, Saudi Arabia for best paediatric blood disorder treatment and second opinions.
3. How do I book an appointment with Dr. Mahasen Saleh?
Appointments with Dr. Mahasen Saleh can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Mahasen Saleh?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Mahasen Saleh, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Mahasen Saleh offer second opinions for Paediatric Hematology — Non-Malignant Blood Disorders cases?
Yes. Second opinion consultations with Dr. Mahasen Saleh can be arranged via Cancer Rounds for patients seeking an expert Paediatric Hematology review of hemophilia management, bleeding-disorder diagnosis, sickle cell and thalassemia care, and HSCT referral in Riyadh, Saudi Arabia.
